Medication safety
The Department of Health oversees a range of strategies to reduce the risk of patient harm from medication-related incidents. These include providing support and expert medication safety advice to public and private health providers and developing and issuing patient safety notifications, fact sheets, practice guidelines, forms and charts.
Guidelines
- Aminoglycoside Dosing in Adults guideline (PDF 931 kB)
- Dabigatran —Guidelines for Managing Patients on Dabigatran (Pradaxa) Who Present to Hospital
- Factor Xa inhibitors (PDF 292 kB)—Guideline for managing patients on a factor Xa inhibitor - Apixaban (Eliquis) or Rivaroxaban (Xarelto)
- Low molecular weight heparins (PDF 217 kB)—Guideline for Anticoagulation and Prophylaxis using Low Molecular Weight Heparin (LMWH) in adult inpatients
- Paracetamol (PDF 242 kB)—Safe paracetamol use guideline
- 2016 Prescribing Electrolyte Disturbances in Adults (PDF 421 kB)
- 2020 Prescribing Electrolyte Disturbances in Adults (PDF 259 kB)
- Prescribing Intravenous Fluids for Adults (PDF 364 kB)
- Warfarin —Guidelines for management of Warfarin in the community
- Venous thromboembolism (VTE) Prevention
Contact
Medication Safety
Telephone: 07 3708 5306
Email: MedicationSafety@health.qld.gov.au
Last updated: 15 September 2020
